11:00AM-1:30 EST | 3-Day Virtual Training Course

The workshop will introduce the general chemical structure of oligonucleotide and then summarise the oligonucleotide medicines currently approved, their type and disease indication. Following this the different modalities will be discussed (ASO SiRNA etc. etc.). A summary of the challenges for this class will be provided. This will be an extensive introduction to set the scene for the rest of the course.

 11:00AM-1:30 EST | 3 Day Online Training Course

Learn how to develop an evolving control strategy for your drug substance — from early development to registration. The course will also discuss the issues and risks that can be developed, addressed and mitigated during development